BJL
ALDR

Brighton Jones LLC’s Alder Biopharmaceuticals ALDR Stock Holding History

Brighton Jones LLC’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-11,815
Closed -$139K – 327
2019
Q2 		$139K Hold
11,815
– – 0.02% 293
2019
Q1 		$161K Hold
11,815
– – 0.02% 294
2018
Q4 		$121K Hold
11,815
– – 0.02% 253
2018
Q3 		$197K Buy
+11,815
New +$214K 0.02% 274

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brighton Jones LLC's ALDR Position: Q3 2019 in Review

Brighton Jones LLC sold out of Alder Biopharmaceuticals (ALDR) in Q3 2019, closing a stake of 11,815 shares — an estimated $139K sold.

Brighton Jones LLC first reported a position in ALDR in Q3 2018 and held it in 4 quarters. The position peaked at $197K in Q3 2018. 143 funds tracked by Wall St. Rank hold ALDR as of Q3 2019.

  • Brighton Jones LLC reported no remaining Alder Biopharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Brighton Jones LLC sold 11,815 Alder Biopharmaceuticals shares in Q3 2019, an estimated $139K.
  • Brighton Jones LLC first reported a position in Alder Biopharmaceuticals in Q3 2018 and held it in 4 quarters.
  • Brighton Jones LLC's Alder Biopharmaceuticals position peaked at $197K in Q3 2018.
  • 143 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2019.

Based on Brighton Jones LLC's 13F filing for Q3 2019, filed 28 Oct 2019.